Skip to content

Clinical trial of Modified microneedle in the treatment of severe alopecia areata

Clinical trial of Modified microneedle in the treatment of severe alopecia areata

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035884
Enrollment
Unknown
Registered
2020-08-19
Start date
2020-10-10
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alopecia areata

Interventions

modified microneedle:temperature controlled
traditional microneedle:microneedle treatment

Sponsors

Shanghai Dermatology Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for severe alopecia areata: refer to the diagnostic criteria for alopecia areata established by "Clinical Dermatology" and the National Alopecia areata Research Group; 2. Aged 16 to 70 years old; 3. Those who agree to participate in clinical trials and can cooperate with scheduled follow-ups.

Exclusion criteria

Exclusion criteria: 1. Suffer from organic digestive tract diseases, such as peptic ulcer, digestive tract tumor, inflammatory bowel disease, etc.; 2. People with severe heart, liver, kidney insufficiency, diabetes and other diseases; 3. Suffer from mental illness, including severe hysteria; those who do not have the ability to autonomously; 4. Those who are allergic or intolerant to this product; 5. Women who are pregnant or breastfeeding, or women who plan to become pregnant; 6. Participated in other clinical trials in the last 3 months; 7. Any medical history, according to the researcher's judgment, may interfere with the test results or increase the patient's risk.

Design outcomes

Primary

MeasureTime frame
TAHC;

Countries

China

Contacts

Public ContactJing Zhou

Shanghai Dermatology Hospital

vine_vs_vine@126.com+86 18017336871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026